Protective effect of Asarum sieboldii essential oil on ovalbumin induced allergic rhinitis in rat.


Journal

Bioscience reports
ISSN: 1573-4935
Titre abrégé: Biosci Rep
Pays: England
ID NLM: 8102797

Informations de publication

Date de publication:
26 06 2020
Historique:
received: 07 05 2019
revised: 24 04 2020
accepted: 07 05 2020
pubmed: 13 5 2020
medline: 31 3 2021
entrez: 13 5 2020
Statut: ppublish

Résumé

The study was aimed to investigate the protective effect of Asarum sieboldii Miq. essential oil (AEO) on ovalbumin (OVA)-induced allergic rhinitis (AR) in rats. Sixty Sprague-Dawley male rats were randomly divided into six groups (n=10): control, model, cetirizine (Cet, 4.65 g/kg), and AEO (0.5, 1.5, 3 g/kg) groups. All animals except the control group received repeated intranasal instillation with 20 μl of 20% OVA in Al(OH)3 saline solvent for 15 days. The control group was intranasally instilled with 5 mg/ml of Al(OH)3 instead of the same procedure. In the 15 days, Cet and AEO were orally administrated for 28 days. At the end of the drug administration, 20 μl of 5% OVA was given to animals to stimulate allergic reaction, then the rat behavioral detection, assessment of the patho-morphological changes in nasal mucosa, and the serum biomarkers were determined. The result showed that AEO could significantly reduce the amount of nasal secretions, sneezing, and the degree of nasal scratching in AR rats with EC50 = 1.5 and 2.8 g/kg, respectively. The degree of nasal mucosal inflammation in AEO group improved, the levels of immunoglobulin E (IgE), histamine, IL-4, IL-5, IL-17 were decreased, and the level of IFN-γ was increased obviously with EC50 = 2 g/kg. The study suggested that the possible mechanism might be related with the inhibition of histamine release and regulation of the cytokine levels, which plays an important role in the treatment of AR.

Sections du résumé

BACKGROUND
The study was aimed to investigate the protective effect of Asarum sieboldii Miq. essential oil (AEO) on ovalbumin (OVA)-induced allergic rhinitis (AR) in rats.
METHODS AND RESULTS
Sixty Sprague-Dawley male rats were randomly divided into six groups (n=10): control, model, cetirizine (Cet, 4.65 g/kg), and AEO (0.5, 1.5, 3 g/kg) groups. All animals except the control group received repeated intranasal instillation with 20 μl of 20% OVA in Al(OH)3 saline solvent for 15 days. The control group was intranasally instilled with 5 mg/ml of Al(OH)3 instead of the same procedure. In the 15 days, Cet and AEO were orally administrated for 28 days. At the end of the drug administration, 20 μl of 5% OVA was given to animals to stimulate allergic reaction, then the rat behavioral detection, assessment of the patho-morphological changes in nasal mucosa, and the serum biomarkers were determined. The result showed that AEO could significantly reduce the amount of nasal secretions, sneezing, and the degree of nasal scratching in AR rats with EC50 = 1.5 and 2.8 g/kg, respectively. The degree of nasal mucosal inflammation in AEO group improved, the levels of immunoglobulin E (IgE), histamine, IL-4, IL-5, IL-17 were decreased, and the level of IFN-γ was increased obviously with EC50 = 2 g/kg.
CONCLUSION
The study suggested that the possible mechanism might be related with the inhibition of histamine release and regulation of the cytokine levels, which plays an important role in the treatment of AR.

Identifiants

pubmed: 32395767
pii: 224117
doi: 10.1042/BSR20191370
pmc: PMC7268255
pii:
doi:

Substances chimiques

Anti-Allergic Agents 0
Cytokines 0
Drugs, Chinese Herbal 0
Oils, Volatile 0
Plant Oils 0
Immunoglobulin E 37341-29-0
asarum oil 8016-69-1
Histamine 820484N8I3
Ovalbumin 9006-59-1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : ExpressionOfConcernIn

Informations de copyright

© 2020 The Author(s).

Références

Cell Mol Biol (Noisy-le-grand). 2018 Sep 30;64(12):52-55
pubmed: 30301503
Expert Rev Clin Immunol. 2018 Nov;14(11):957-964
pubmed: 30261765
J Econ Entomol. 2015 Jun;108(3):1208-14
pubmed: 26470247
Phytother Res. 2014 Feb;28(2):231-7
pubmed: 23580257
Eur J Pharmacol. 2018 Nov 5;838:107-111
pubmed: 30201377
Zhong Yao Cai. 2012 Feb;35(2):188-94
pubmed: 22822661
Adv Exp Med Biol. 2010;684:1-10
pubmed: 20795536
Hepatogastroenterology. 2012 Sep;59(118):1809-13
pubmed: 23115792
Parasitol Res. 2012 Nov;111(5):1895-9
pubmed: 22833176
Bioorg Med Chem Lett. 2012 Apr 1;22(7):2527-33
pubmed: 22381047
Front Pediatr. 2018 Sep 11;6:250
pubmed: 30255006
J Med Food. 2006 Winter;9(4):505-9
pubmed: 17201637
Pak J Med Sci. 2018 Sep-Oct;34(5):1288-1292
pubmed: 30344593
Int Arch Otorhinolaryngol. 2018 Oct;22(4):428-431
pubmed: 30357064
Aust J Gen Pract. 2018 Sep;47(9):632-637
pubmed: 30244562
Allergy Asthma Immunol Res. 2018 Nov;10(6):675-685
pubmed: 30306749
Biomed Rep. 2014 May;2(3):437-441
pubmed: 24748990
Curr Opin Immunol. 2011 Dec;23(6):784-8
pubmed: 22019285
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Oct 7;53(10):798-800
pubmed: 30347544
Exp Ther Med. 2018 Nov;16(5):3996-4004
pubmed: 30344677
Ann Allergy Asthma Immunol. 2019 Feb;122(2):160-166.e1
pubmed: 30321655
J Immunol. 2011 Dec 15;187(12):6417-27
pubmed: 22079980
Dokl Biol Sci. 2009 Jan-Feb;424:14-7
pubmed: 19341074
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Oct 7;53(10):721-724
pubmed: 30347528
Int Immunopharmacol. 2018 Dec;65:182-189
pubmed: 30316076
Neuroscience. 2018 Nov 10;392:172-179
pubmed: 30278251
Curr Allergy Asthma Rep. 2018 Oct 20;18(12):68
pubmed: 30343453
Drugs Aging. 2017 Jan;34(1):21-28
pubmed: 27913982
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Sep 7;53(9):675-679
pubmed: 30293259
Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2018 Sep;32(17):1363-1366
pubmed: 30282197

Auteurs

Zhicheng Zhang (Z)

Department of Otorhinolaryngology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, People's Republic of China.

Haoran Kang (H)

Department of Otorhinolaryngology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, People's Republic of China.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH